Search - tctmd.com

Displaying 1 - 20 of 872

Sort: Relevancy | Date

News Daily News

Leaflet Thickening, Valve Durability After Balloon-Expandable TAVR: Studies Offer New Insights

Todd Neale

December 26, 2016

News Daily News

Women More Likely to be Alive 1 Year After TAVR: STS/ACC TVT Registry

Michael O'Riordan

December 19, 2016

News Daily News

Under Surveillance: Ballooning Numbers, Better Survival, Lower-Risk Patients in Latest TVT Registry Data

L.A. McKeown

December 13, 2016

News Daily News

Believe It: Mitral Valve Repair Beats Replacement for Severe Regurgitation, Registry Shows

Shelley Wood

December 05, 2016

News Industry News

Cardiac Dimensions Announces Investigational Device Exemption Approval from FDA to Conduct U.S. Pivotal Study of the Carillon Mitral Contour System for Functional Mitral Regurgitation

December 01, 2016

News Daily News

After a Lull, Cardioband Purchase Represents Latest in Mitral Valve Tech Acquisitions

Shelley Wood

November 30, 2016

News Daily News

Conduction Problems Requiring Permanent Pacemakers Continue to Vex TAVR Field

Todd Neale

November 08, 2016

Presentation TCT 2016

Surgical Approach to Functional Tricuspid Regurgitation

Presenter: Joachim Schofer, Alec S. Vahanian, Joerg Seeburger

November 01, 2016

Presentation TCT 2016

Impact and Natural History of Functional Tricuspid Regurgitation

Presenter: Joachim Schofer, Alec S. Vahanian, Maurice E. Sarano

November 01, 2016

Presentation TCT 2016

TCT 1620: First-In-Human of Transapical Off-Pump Mitral Valve Repair With Catheter Delivered Annuloplasty Ring for Functional Mitral Regurgitation

Presenter: Ruediger S. Lange, John F. Rhodes, Andrea Colli

November 01, 2016

Presentation TCT 2016

Pulmonic Stenosis and Regurgitation: Pathophysiology and Review of Indications for Intervention

Presenter: Ziyad M. Hijazi, C. Huie Lin, Bryan H. Goldstein

November 01, 2016

News Conference News TCT 2016

Midterm Durability of TAVR Valves: PARTNER, Other Studies Boost Confidence

Todd Neale

November 01, 2016

Presentation TCT 2016

Early Feasibility of a Percutaneous Tricuspid Valve Annuloplasty System for Symptomatic Chronic Functional Tricuspid Regurgitation: 30-Day Results From the SCOUT Trial

Presenter: Ted Feldman, David Hildick-Smith, Rebecca T. Hahn

November 01, 2016

Presentation TCT 2016

The ELECT Trial: A Randomized Evaluation of Periprosthetic Regurgitation After TAVI With Sapien 3 or CoreValve Using Mulit-Modality Imaging

Presenter: Neil E. Moat, John G. Webb, Pieter R. Stella

October 31, 2016

Presentation TCT 2016

Trial #7 - The Essentials ofCTSN SMR Trial - Two-Year Outcomes Following Mitral Valve Repair or Replacement for Severe Ischemic Mitral Regurgitation

Presenter: William A. Gray, Stephan Windecker, Michael Argenziano

October 31, 2016

Presentation TCT 2016

Von Willebrand Factor Multimers During TAVR: Implications for Treatment of Para-Valvular Regurgitation

Presenter: Neil E. Moat, John G. Webb, Eric Van Belle

October 31, 2016

Presentation TCT 2016

A Practical Algorithm for Managing Para-Valvular Regurgitation After TAVR

Presenter: Neil E. Moat, John G. Webb, Scott Lim

October 31, 2016

Presentation TCT 2016

Complications 1. Para-Valvular Regurgitation: Should Mild Para-Valvular Regurgitation After TAVR Be Treated?

Presenter: Neil E. Moat, John G. Webb, Jeffrey J. Popma

October 31, 2016

Presentation TCT 2016

Ventricular Reshaping: From CorCap to VenTouch

Presenter: Ted Feldman, Scott Lim

October 31, 2016

Presentation TCT 2016

Update on Artificial Chords II: Harpoon

Presenter: Ted Feldman, Scott Lim, James S. Gammie

October 31, 2016

Advertisement

Leaflet Thickening, Valve Durability After Balloon-Expandable TAVR: Studies Offer New Insights

Women More Likely to be Alive 1 Year After TAVR: STS/ACC TVT Registry

Under Surveillance: Ballooning Numbers, Better Survival, Lower-Risk Patients in Latest TVT Registry Data

Believe It: Mitral Valve Repair Beats Replacement for Severe Regurgitation, Registry Shows

Cardiac Dimensions Announces Investigational Device Exemption Approval from FDA to Conduct U.S. Pivotal Study of the Carillon Mitral Contour System for Functional Mitral Regurgitation

After a Lull, Cardioband Purchase Represents Latest in Mitral Valve Tech Acquisitions

Conduction Problems Requiring Permanent Pacemakers Continue to Vex TAVR Field

Surgical Approach to Functional Tricuspid Regurgitation

Impact and Natural History of Functional Tricuspid Regurgitation

TCT 1620: First-In-Human of Transapical Off-Pump Mitral Valve Repair With Catheter Delivered Annuloplasty Ring for Functional Mitral Regurgitation

Pulmonic Stenosis and Regurgitation: Pathophysiology and Review of Indications for Intervention

Midterm Durability of TAVR Valves: PARTNER, Other Studies Boost Confidence

Early Feasibility of a Percutaneous Tricuspid Valve Annuloplasty System for Symptomatic Chronic Functional Tricuspid Regurgitation: 30-Day Results From the SCOUT Trial

The ELECT Trial: A Randomized Evaluation of Periprosthetic Regurgitation After TAVI With Sapien 3 or CoreValve Using Mulit-Modality Imaging

Trial #7 - The Essentials ofCTSN SMR Trial - Two-Year Outcomes Following Mitral Valve Repair or Replacement for Severe Ischemic Mitral Regurgitation

Von Willebrand Factor Multimers During TAVR: Implications for Treatment of Para-Valvular Regurgitation

A Practical Algorithm for Managing Para-Valvular Regurgitation After TAVR

Complications 1. Para-Valvular Regurgitation: Should Mild Para-Valvular Regurgitation After TAVR Be Treated?

Ventricular Reshaping: From CorCap to VenTouch

Update on Artificial Chords II: Harpoon

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content